Ascorbic acid antagonizes nicotine-induced place preference and behavioral sensitization in mice

European Journal of Pharmacology

Volumn 560, Issue 1, 2007, Pages 42-48

  Sahraei, Hedayat ^a   Aliabadi, Ali Akbar ^b   Zarrindast, Mohammad Reza ^c   Ghoshooni, Hassan ^a   Nasiri, Ali ^a   Barzegari Sorkheh, Amir Abbas ^a   Yari, Maryam ^b   Zardooz, Homeira ^d   Hossein Mardi, Leila ^b   Faraji, Nasrin ^b   Shams, Jamal ^d  

^a BAQIYATALLAH UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b ISLAMIC AZAD UNIVERSITY   (Iran)

^c TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^d SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

(Mice); Ascorbic acid; Behavioral sensitization; Nicotine; Place preference

Indexed keywords

ASCORBIC ACID; DOPAMINE; NICOTINE;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ARTICLE; CHEMOSENSITIZATION; CONTROLLED STUDY; DOPAMINERGIC SYSTEM; DOSE RESPONSE; DRUG EFFECT; FEMALE; NONHUMAN; PLACE PREFERENCE; PRIORITY JOURNAL; TOBACCO DEPENDENCE;

ANIMALS; ASCORBIC ACID; BEHAVIOR, ANIMAL; CONDITIONING, OPERANT; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; INJECTIONS, INTRAPERITONEAL; MICE; MOTOR ACTIVITY; NICOTINE; NICOTINIC AGONISTS; VITAMINS;

EID: 33847335965     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2006.12.019     Document Type: Article

References (32)

1. Baker T.B., Brandon T.H., and Chassin L. Motivational influences on cigarette smoking. Annu. Rev. Psychol. 55 (2004) 463-491
2. Balfour D.J.K., Benwell M.E.M., Birrell C.E., Kelly R.J., and Al-Aloul M. Sensitization of the mesoaccumbens dopamine response to nicotine. Pharmacol. Biochem. Behav. 59 (1998) 1021-1030
3. Biala G. Calcium channel antagonists suppress nicotine-induced place preference and locomotor sensitization in rodents. Pol. J. Pharmacol. 55 (2003) 327-335
4. Booze R.M., Welch M.A., Wood M.L., Billings K.A., Apple S.R., and Mactutus C.F. Behavioral sensitization following repeated intravenous nicotine administration: gender differences and gonadal hormones. Pharmacol. Biochem. Behav. 64 (1999) 827-839
5. Brazell M.P., Mitchell S.N., Joseph M.H., and Gray J.A. Acute administration of nicotine increases the in vivo extracellular levels of dopamine, 3,4-dihydroxyphenylacetic acid and ascorbic acid preferentially in the nucleus accumbens of the rat: comparison with caudate-putamen. Neuropharmacology 29 (1990) 1177-1185
6. Cadoni C., and Di Chiara G. Differential changes in accumbens shell and core dopamine in behavioral sensitization to nicotine. Eur. J. Pharmacol. 387 (2000) R23-R25
7. Dawson E.B., Evans D.R., Harris W.A., and McGanity W.J. The effect of ascorbic acid supplementation on the nicotine metabolism of smokers. Prev. Med. 29 (1999) 451-454
8. de Angelis L. Ascorbic acid and atypical antipsychotic drugs: modulation of amineptine-induced behavior in mice. Brain Res. 670 (1995) 303-307
9. Debler E.A., Hashim A., Lajtha A., and Sershen H. Ascorbic acid and striatal transport of [3H] 1-methyl-4-phenylpyridine (MPP+) and [3H] dopamine. Life Sci. 42 (1988) 2553-2559
10. Di Chiara G. Role of dopamine in the behavioral actions of nicotine related to addiction. Eur. J. Pharmacol. 393 (2000) 295-314
11. Fu Y., Matta S.G., Gao W., Brower V.G., and Sharp B.M. Systemic nicotine stimulates dopamine release in nucleus accumbens: re-evaluation of the role of n-methyl-d-aspartate receptors in the ventral tegmental area. J. Pharmacol. Exp. Ther. 294 (2000) 458-465
12. Garthwaite J., Southam E., and Anderton M. A kainite receptor, linked to nitric oxide synthesis from arginine. J. Neurochem. 53 (1989) 1952-1954
13. Gu P.F., Yang J.Y., Wu C.F., Li W., and Shang Y. Frontal decortication eliminates drug-induced ascorbic acid release in the striatum but not the nucleus accumbens of freely moving rats. Brain Res. 1033 (2005) 194-201
14. Gu P.F., Wu C.F., Yang J.Y., Shang Y., Hou Y., Bi X.L., and Dai F. Differential effects of drug-induced ascorbic acid release in the striatum and nucleus accumbens of freely moving rats. Neurosci. Lett. 399 (2006) 79-84
15. Halimi J.M., and Mimran A. Systemic and renal effect of nicotine in non-smokers: influence of vitamin C. J. Hypertens. 18 (2000) 1665-1669
16. Heikkila R.E., Cabbat F.S., and Manzino L. Differential inhibitory effects of ascorbic acid on the binding of dopamine agonist and antagonist to neostriatal membrane preparations: correlations with behavioral effects. Res. Commun. Chem. Pathol. Pharmacol. 34 (1981) 409-421
17. Kelly G. The interaction of cigarette smoking and antioxidants. Part III: ascorbic acid. Altern. Med. Rev. 8 (2003) 43-54
18. Kim S.H., Ensunsa J.L., Zhu Q.Y., Kim J.S., Shin H.S., and Keen C.L. An 18-month follow-up study on the influence of smoking on blood antioxidant status of teenage girls in comparison with adult male smokers in Korea. Nutrition 20 (2004) 437-444
19. Levin E.D., Behm F., Carnahan E., LeClair R., Shipley R., and Rose J.E. Clinical trials using ascorbic acid aerosol to aid smoking cessation. Drug Alcohol Depend. 33 (1993) 211-223
20. Miquel M., Aguilar M.A., and Aragon C.M.G. Ascorbic acid antagonizes ethanol-induced locomotor activity in the open-field. Pharmacol. Biochem. Behav. 62 (1999) 361-366
21. Picciotto M.R. Nicotine as a modulator of behavior: beyond the inverted U. Trends Pharmacol. Sci. 24 (2003) 493-499
22. Pierce R.C., Rowlett K., Rebec G.V., and Bardo M.T. Ascorbate potentiates amphetamine-induced conditioned place preference and forebrain dopamine release in rats. Brain Res. 688 (1995) 21-26
23. Pomerleau O.F. Endogenous opioid and smoking: a review of progress and problems. Psychoneuroendocrinology 23 (1998) 115-130
24. Rebec G.V., and Pierce R.C. A vitamin as neuromodulator: ascorbate release into the extracellular fluid of the brain regulates dopaminergic and glutamatergic transmission. Prog. Neurobiol. 43 (1994) 537-565
25. Rebec G.V., and Wang Z. Behavioral activation in rats requires endogenous ascorbate release in striatum. J. Neurosci. 21 (2001) 668-675
26. Rice M.E. Ascorbate regulation and its neuroprotective role in the brain. Trends Neurosci. 23 (2000) 209-216
27. Sahraei H., Falahi M., Zarrindast M.R., Sabetkasaei M., Ghoshooni H., and Khalili M. The effects of nitric oxide on the acquisition and expression of nicotine-induced conditioned place preference in mice. Eur. J. Pharmacol. 503 (2004) 81-87
28. Shim I., Kim H.T., Kim Y.H., Chun B.G., Hahm D.H., Lee E.H., Kim S.E., and Lee H.J. Role of nitric oxide synthase inhibitors and NMDA receptor antagonist in nicotine-induced behavioral sensitization in the rat. Eur. J. Pharmacol. 443 (2002) 119-124
29. Tolbert L.C., Morris P.E., Spollen J.J., and Ashe S.C. Streospecific effect of ascorbic acid and analogues of D1 and D2 agonist binding. Life Sci. 51 (1992) 921-930
30. Vleeming W., Rambali B., and Opperhuizen A. The role of nitric oxide in cigarette smoking and nicotine addiction. Nicotine Tob. Res. 4 (2002) 341-348
31. Wonnacott S., Sidhpura N., and Balfour D.J.K. Nicotine: from molecular mechanisms to behaviour. Curr. Opin. Pharmacol. 5 (2005) 53-59
32. Zarrindast M.R., Faraji N., Rostami P., Sahraei H., and Ghoshouni H. Cross-tolerance between morphine-and nicotine-induced conditioned place preference in mice. Pharmacol. Biochem. Behav. 74 (2003) 363-369